Among the death receptors explored for cancer treatment, receptors belonging to the pro-apoptotic pathway of the TNF-related apoptosis-inducing ligand (TRAIL) has gained interest and even entered in clinical trials in combination with cytotoxic chemotherapy. The gene discussed is TNFSF10; the disease is cancer.